Red Abbey Venture Partners
17
25M
13
0.94
0.24
5
- Stages of investment
- Areas of investment
Summary
Red Abbey Venture Partners appeared to be the VC, which was created in 2004. The main department of described VC is located in the Baltimore. The fund was located in North America if to be more exact in United States.
Deals in the range of 10 - 50 millions dollars are the general things for fund. This Red Abbey Venture Partners works on 9 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2005. The top amount of exits for fund were in 2014. The fund is generally included in less than 2 deals every year.
We also calculated 2 valuable employees in our database.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Red Abbey Venture Partners, startups are often financed by Rho Ventures, MedImmune Ventures, MPM Capital. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Alta Partners, SV Health Investors. In the next rounds fund is usually obtained by InterWest Partners, TPG, Alta Partners.
Among the most popular portfolio startups of the fund, we may highlight Anacor Pharmaceutical, Nereus Pharmaceuticals, Oxagen. Among the most popular fund investment industries, there are Mobile, Health Care. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 17
- Lead investments
- 0
- Exits
- 5
- Rounds per year
- 0.94
- Follow on index
- 0.24
- Investments by industry
- Biotechnology (14)
- Health Care (11)
- Medical (6)
- Therapeutics (5)
- Biopharma (4) Show 12 more
- Investments by region
-
- United States (12)
- United Kingdom (3)
- Canada (1)
- Peak activity year
- 2005
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 89M
- Group Appearance index
- 1.00
- Avg. company exit year
- 6
- Avg. multiplicator
- 0.96
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CanopyLAB | 26 Jan 2020 | E-Learning, SaaS, Education | Seed | 1M | Capital Region of Denmark, Copenhagen, Denmark |
| MacroGenics | 17 May 2006 | Biotechnology, Health Care, Manufacturing | Late Stage Venture | 45M | United States, Maryland |
| Perceiv AI | 08 Dec 2022 | Analytics, Artificial Intelligence, Machine Learning, Health Care, Health Diagnostics, Medical, Pharmaceutical, Predictive Analytics, Clinical Trials | Seed | 1M | Quebec, Montréal, Canada |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.